| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8443595 | European Journal of Cancer | 2014 | 10 Pages |
Abstract
These data may suggest that the MoA of imgatuzumab involves ADCC-related immune effects in the tumour and is not limited to simple receptor blockade.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jean-Pierre Delord, Josep Tabernero, RocÃo GarcÃa-Carbonero, Andres Cervantes, Carlos Gomez-Roca, Yann Bergé, Jaume Capdevila, Luis Paz-Ares, Desamparados Roda, Paul Delmar, David Oppenheim, Sophia Soehrman Brossard, Farzin Farzaneh, Luigi Manenti,